Exchange: NASDAQ·Updated 04:04 PM EDT

JATTJatt II Acquisition Corp.

$10.56
$0.11
(1.02%)
Today
Closed $10.65
$0.09
(0.84%)
After Hours
Mkt Cap$86.35M
Vol8,784.00
News
all
press releases
News Placeholder
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business...
PR Newswire
<
...
1
>